Midwest Trust Co acquired a new stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 2nd quarter, Holdings Channel reports. The firm acquired 34,244 shares of the semiconductor company’s stock, valued at approximately $17,556,000.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. Saudi Central Bank acquired a new position in Synopsys during the 1st quarter valued at $26,000. Clal Insurance Enterprises Holdings Ltd increased its holdings in shares of Synopsys by 441.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 53 shares during the period. Independence Bank of Kentucky increased its holdings in shares of Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 30 shares during the period. Princeton Global Asset Management LLC raised its position in shares of Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after buying an additional 53 shares during the last quarter. Finally, WPG Advisers LLC bought a new stake in shares of Synopsys in the first quarter valued at about $34,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Trading Down 0.7%
SNPS stock opened at $393.43 on Friday. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The firm has a market cap of $73.08 billion, a P/E ratio of 30.88, a P/E/G ratio of 5.02 and a beta of 1.10. The business’s 50 day moving average is $475.14 and its 200-day moving average is $514.87. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52.
Analyst Ratings Changes
SNPS has been the topic of several research reports. KeyCorp lowered their price target on Synopsys from $660.00 to $590.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. Citigroup downgraded Synopsys from a “neutral” rating to an “underperform” rating in a research report on Wednesday, September 10th. JPMorgan Chase & Co. lowered their price objective on Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 10th. Needham & Company LLC cut their target price on Synopsys from $660.00 to $550.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Finally, Bank of America reaffirmed an “underperform” rating and issued a $525.00 target price (down from $625.00) on shares of Synopsys in a research report on Wednesday, September 10th. Ten investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $569.67.
View Our Latest Analysis on SNPS
Insider Buying and Selling
In other news, CFO Shelagh Glaser sold 3,655 shares of the business’s stock in a transaction on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the sale, the chief financial officer owned 15,317 shares in the company, valued at approximately $9,339,847.09. The trade was a 19.27% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the company’s stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the sale, the chief executive officer directly owned 71,615 shares in the company, valued at approximately $42,181,951.15. The trade was a 13.70% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 30,894 shares of company stock valued at $16,760,783 in the last ninety days. Insiders own 0.62% of the company’s stock.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- P/E Ratio Calculation: How to Assess Stocks
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- What Investors Need to Know to Beat the Market
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
